• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸收速率等效性的灵敏且特异的测定。

Sensitive and specific determination of the equivalence of absorption rates.

作者信息

Endrenyi L, Al-Shaikh P

机构信息

Department of Pharmacology, University of Toronto, Ontario.

出版信息

Pharm Res. 1995 Dec;12(12):1856-64. doi: 10.1023/a:1016267200905.

DOI:10.1023/a:1016267200905
PMID:8786956
Abstract

PURPOSE

To develop a new method for the direct, sensitive evaluation of the equivalence of absorption rates in linear kinetic systems.

METHODS

Concentrations are obtained before the earlier peak. Ratios of concentrations adjusted for the corresponding ratio of AUCs (area under the curve contrasting plasma concentration with time), or their logarithm, are extrapolated by linear regression to the time of drug administration. The intercept estimates the ratio of absorption rate constants (ka), or its logarithm.

RESULTS

The intercept metric assesses the equivalence of absorption rates with very favourable characteristics. The metric reflects the ka-ratio specifically (i.e., not affected by other kinetic parameters), is approximately linear to it, exhibits high kinetic sensitivity and excellent statistical properties. With many observations, the intercept metric has near-ideal features, including high power for determining bioequivalence and the ability to detect a 25% difference between ka values. With only 3 or 4 measurements before the earlier peak, the performance of the metric depends on the preset regulatory conditions. Reasonably good power is noted if the bioequivalence limits determine a 50% difference between two metrics and, approximately, between two ka values. The intercept metric shows very high power with a wider bioequivalence range. The power declines only moderately with increasing intraindividual variation of ka. The equivalence of absorption rates is assessed with much higher power by the intercept metric than by Cmax.

CONCLUSIONS

The excellent kinetic and statistical properties of the intercept metric enable the specific and sensitive determination of the equivalence of absorption rates.

摘要

目的

开发一种用于直接、灵敏地评估线性动力学系统中吸收速率等效性的新方法。

方法

在较早的峰之前获取浓度。根据相应的曲线下面积(AUC,即血浆浓度与时间对比曲线下的面积)比值调整后的浓度比值,或其对数,通过线性回归外推至给药时间。截距估计吸收速率常数(ka)的比值,或其对数。

结果

截距指标评估吸收速率的等效性,具有非常良好的特性。该指标能特异性地反映ka比值(即不受其他动力学参数影响),与其大致呈线性关系,具有高动力学灵敏度和出色的统计学特性。在有许多观测值的情况下,截距指标具有近乎理想的特征,包括确定生物等效性的高功效以及检测ka值之间25%差异的能力。在较早的峰之前仅进行3或4次测量时,该指标的性能取决于预设的监管条件。如果生物等效性限度确定两个指标之间以及大致两个ka值之间存在50%的差异,则可观察到相当不错的功效。截距指标在更宽的生物等效性范围内显示出非常高的功效。随着ka个体内变异的增加,功效仅适度下降。与Cmax相比 使用截距指标评估吸收速率的等效性具有更高的功效。

结论

截距指标出色的动力学和统计学特性能够特异性且灵敏地确定吸收速率的等效性。

相似文献

1
Sensitive and specific determination of the equivalence of absorption rates.吸收速率等效性的灵敏且特异的测定。
Pharm Res. 1995 Dec;12(12):1856-64. doi: 10.1023/a:1016267200905.
2
Metrics comparing simulated early concentration profiles for the determination of bioequivalence.用于生物等效性测定的模拟早期浓度曲线比较指标。
Pharm Res. 1998 Aug;15(8):1292-9. doi: 10.1023/a:1011912512966.
3
Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.在生物等效性研究中,对于吸收速率而言,Cmax/AUC比Cmax是更清晰的衡量指标。
Int J Clin Pharmacol Ther Toxicol. 1991 Oct;29(10):394-9.
4
The duration of measuring partial AUCs for the assessment of bioequivalence.用于评估生物等效性的部分AUC测量持续时间。
Pharm Res. 1998 Mar;15(3):399-404. doi: 10.1023/a:1011916113082.
5
Sensitivity of empirical metrics of rate of absorption in bioequivalence studies.生物等效性研究中吸收速率经验指标的敏感性。
Pharm Res. 2000 May;17(5):583-8. doi: 10.1023/a:1007521016985.
6
Variation of Cmax and Cmax/AUC in investigations of bioequivalence.生物等效性研究中Cmax和Cmax/AUC的变异
Int J Clin Pharmacol Ther Toxicol. 1993 Apr;31(4):184-9.
7
Absorption rate vs. exposure: which is more useful for bioequivalence testing?吸收速率与暴露量:哪一个对生物等效性测试更有用?
Pharm Res. 1996 Mar;13(3):453-6. doi: 10.1023/a:1016061013606.
8
Bioequivalence: performance of several measures of extent of absorption.生物等效性:吸收程度的几种测量指标的表现。
Pharm Res. 1994 May;11(5):715-22. doi: 10.1023/a:1018932430733.
9
The role of metabolites in bioequivalency assessment. III. Highly variable drugs with linear kinetics and first-pass effect.代谢物在生物等效性评估中的作用。III. 具有线性动力学和首过效应的高可变药物。
Pharm Res. 2000 Nov;17(11):1432-6. doi: 10.1023/a:1007581016352.
10
Evaluation of direct curve comparison metrics applied to pharmacokinetic profiles and relative bioavailability and bioequivalence.应用于药代动力学曲线、相对生物利用度和生物等效性的直接曲线比较指标的评估。
Pharm Res. 1997 Oct;14(10):1363-9. doi: 10.1023/a:1012160419520.

引用本文的文献

1
A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence.一种评估临床试验的向量理论:在生物等效性中的应用。
J Cardiovasc Dev Dis. 2024 Jun 21;11(7):185. doi: 10.3390/jcdd11070185.
2
An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence.生物等效性中合适吸收速率指标的计算机模拟方法。
Pharmaceuticals (Basel). 2023 May 10;16(5):725. doi: 10.3390/ph16050725.
3
The Two Main Goals of Bioequivalence Studies.生物等效性研究的两个主要目标。

本文引用的文献

1
Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies.在比较药代动力学研究中对不同药物吸收速率间接测量方法的评估。
J Pharm Sci. 1994 Feb;83(2):212-5. doi: 10.1002/jps.2600830219.
2
Bioequivalence: performance of several measures of extent of absorption.生物等效性:吸收程度的几种测量指标的表现。
Pharm Res. 1994 May;11(5):715-22. doi: 10.1023/a:1018932430733.
3
Bioequivalence: performance of several measures of rate of absorption.生物等效性:几种吸收速率测量指标的表现
AAPS J. 2017 Jul;19(4):885-890. doi: 10.1208/s12248-017-0048-x. Epub 2017 Feb 2.
4
Measures of exposure versus measures of rate and extent of absorption.暴露量度与吸收速率及吸收程度量度
Clin Pharmacokinet. 2001;40(8):565-72. doi: 10.2165/00003088-200140080-00001.
5
Sensitivity of empirical metrics of rate of absorption in bioequivalence studies.生物等效性研究中吸收速率经验指标的敏感性。
Pharm Res. 2000 May;17(5):583-8. doi: 10.1023/a:1007521016985.
6
Metrics comparing simulated early concentration profiles for the determination of bioequivalence.用于生物等效性测定的模拟早期浓度曲线比较指标。
Pharm Res. 1998 Aug;15(8):1292-9. doi: 10.1023/a:1011912512966.
7
The duration of measuring partial AUCs for the assessment of bioequivalence.用于评估生物等效性的部分AUC测量持续时间。
Pharm Res. 1998 Mar;15(3):399-404. doi: 10.1023/a:1011916113082.
Pharm Res. 1994 Jul;11(7):966-74. doi: 10.1023/a:1018970901116.
4
Sensitivity of indirect metrics for assessing "rate" in bioequivalence studies--moving the "goalposts" or changing the "game".生物等效性研究中评估“速率”的间接指标的敏感性——移动“球门柱”还是改变“游戏规则”。
J Pharm Sci. 1994 Nov;83(11):1554-7. doi: 10.1002/jps.2600831107.
5
Without extrapolation, Cmax/AUC is an effective metric in investigations of bioequivalence.在不进行外推的情况下,Cmax/AUC是生物等效性研究中的一个有效指标。
Pharm Res. 1995 Jun;12(6):937-42. doi: 10.1023/a:1016237826520.
6
A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.两种单侧检验方法与评估平均生物利用度等效性的效能法的比较。
J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80. doi: 10.1007/BF01068419.
7
Update on the statistical analysis of bioequivalence studies.生物等效性研究的统计分析最新进展。
Int J Clin Pharmacol Ther Toxicol. 1990 Mar;28(3):105-10.
8
Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.在生物等效性研究中,对于吸收速率而言,Cmax/AUC比Cmax是更清晰的衡量指标。
Int J Clin Pharmacol Ther Toxicol. 1991 Oct;29(10):394-9.